Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Phase II/III Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for Small Cell Lung Cancer

NCT02635009 is registered in ClinicalTrials.gov with NRG Oncology as lead sponsor.

NCT NCT02635009
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02635009 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Phase II/III Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for Small Cell Lung Cancer
Lead sponsor
NRG Oncology
Phase
Phase 2/3
Overall status
Completed
Start date
December 22, 2015
Completion date
September 4, 2025
Enrollment
418 (actual)
Sites
281

Conditions

As the registry lists them; a condition with its own page is linked.

extensive stage small cell lung carcinoma, limited stage small cell lung carcinoma